2019 Partners

Antaros Medical

Program Partner

Antaros Medical is pioneering imaging methodologies to design and deliver clinical imaging studies for improved, evidence-based decision making in drug development. The company is specialized in cardio-metabolic diseases (incl. NAFLD/NASH) and oncology. The company has today a global network of collaboration partners and customers, including both big and small drug developing companies, and is a partner in several European collaboration initiatives e.g. Innovative Medicines Initiative (IMI).




Program Partner

Bio Preventive Medicine Corporation (BPM) is a clinical-staged biotech company. BPM has been focused on translating validated and IP-protected biomarkers into diagnostic solutions for unmet clinical needs, especially in DKD and non-proteinuric renal disease. Our first product, DNlite, is a non-invasive urinary test for predicting/monitoring the progression of Diabetic Kidney Disease (DKD). We can help partners in the development of drugs not only for evaluating renal efficacy but also renal safety.




Exhibition Partner

Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research and its adjacent conditions. As a Fresenius Medical Care North America company, Frenova manages clinical research assets and resources including over 450 principal investigators at more than 260 sites representing 160 medical practices. Frenova’s F1RST Up® network of select investigative sites provides sponsors with accelerated study startup, while Frenova’s SMO manages clinical research staff and streamlines trial operations to help investigators enroll more patients and perform more studies.